enzalutamide
Showing 26 - 50 of 183
Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)
Not yet recruiting
- Metastatic Cancer
- Neoplasm, Prostate
- Abiraterone acetate
- +2 more
-
Bronx, New YorkJames J. Peters VA Medical Center
Jun 16, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
- Enzalutamide
-
San Francisco, California
- +1 more
Sep 20, 2022
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco (FOR46, Enzalutamide, Pegfilgrastim)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- FOR46
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 1, 2022
Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,
Completed
- Prostate Adenocarcinoma
- +2 more
- Enzalutamide
- +3 more
-
Baltimore, Maryland
- +3 more
Mar 30, 2022
Prostatic Tumors, Castration-Resistant Trial in Leiden (Patient-specific adaptive therapy, Abiraterone acetate, Enzalutamide)
Recruiting
- Prostatic Neoplasms, Castration-Resistant
- Patient-specific adaptive therapy
- +2 more
-
Camperdown, New South Wales, Australia
- +6 more
Jan 11, 2023
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Scottsdale, Jacksonville, Rochester
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- Stage IVB Prostate Cancer AJCC v8
- Biopsy
- +7 more
-
Scottsdale, Arizona
- +2 more
Feb 15, 2023
Prostate Cancer Trial in Washington, Chicago, Baltimore (Enzalutamide, LY2157299)
Recruiting
- Prostate Cancer
- Enzalutamide
- LY2157299
-
Washington, District of Columbia
- +3 more
Jun 1, 2022
Prostate Cancer Trial in Japan (Enzalutamide)
Completed
- Prostate Cancer
- Enzalutamide
-
Kita-gun, Kagawa-prefecture, Japan
- +3 more
May 24, 2022
Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore
Recruiting
- Prostate Cancer
- +2 more
- Testosterone Undecanoate
- Enzalutamide
-
Baltimore, MarylandJohns Hopkins Hospital
May 6, 2022
Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston
Recruiting
- Advanced Breast Carcinoma
- +17 more
- Alpelisib
- Enzalutamide
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)
Completed
- Prostate Cancer Metastatic
- Enzalutamide
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 6, 2022
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Enzalutamide,
Active, not recruiting
- Metastatic Prostate Carcinoma
- +2 more
- Enzalutamide
- Niclosamide
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Feb 23, 2022
Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 11C or 18F-Choline PET/CT, Whole body MRI)
Completed
- Prostate Cancer Metastatic
- Enzalutamide
- +3 more
-
Leiden, NetherlandsLeiden University Medical Center
Apr 6, 2022
Prostate Cancer Trial in Chisinau (enzalutamide, enzalutamide Placebo, digoxin)
Completed
- Prostate Cancer
- enzalutamide
- +3 more
-
Chisinau, Moldova, Republic ofSite MD37301
Jan 14, 2022
Prostatic Cancer, Castration-Resistant Trial in United States (Darolutamide(Nubeqa, BAY1841788), Enzalutamide)
Completed
- Prostatic Cancer, Castration-Resistant
- Darolutamide(Nubeqa, BAY1841788)
- Enzalutamide
-
Portland, Maine
- +6 more
Aug 18, 2022
Metastatic Castration-Resistant Prostate Cancer Trial in China, United States (ZEN003694, Enzalutamide)
Recruiting
- Metastatic Castration-Resistant Prostate Cancer
- ZEN003694
- Enzalutamide
-
San Francisco, California
- +21 more
Aug 18, 2022
Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)
Recruiting
- Metastatic Prostate Cancer
- +3 more
- Darolutamide
- Enzalutamide
-
San Diego, California
- +11 more
Nov 28, 2022
Prostate Cancer, Bone Metastases Trial in Brescia (Zoledronic Acid, Enzalutamide)
Recruiting
- Prostate Cancer
- Bone Metastases
- Zoledronic Acid
- Enzalutamide
-
Brescia, ItalyAzienda Ospedaliera Spedali Civili di Brescia
Mar 4, 2022
Castration-resistant Prostate Cancer Trial in Boston (Crizotinib, Enzalutamide)
Completed
- Castration-resistant Prostate Cancer
- Crizotinib
- Enzalutamide
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 5, 2022
Prostate Cancer, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide, CC-115)
Active, not recruiting
- Prostate Cancer
- Castration Resistant Prostate Cancer
- Enzalutamide
- CC-115
-
San Francisco, California
- +4 more
Mar 18, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Portland, Seattle
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +3 more
- Cabazitaxel
- +4 more
-
Portland, Oregon
- +2 more
Jun 24, 2022
Prostate Cancer, Prostatic Cancer, Cancer of Prostate Trial (NUV-422, Enzalutamide)
Not yet recruiting
- Prostate Cancer
- +7 more
- NUV-422
- Enzalutamide
- (no location specified)
Jan 12, 2022
Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo
Recruiting
- Castration-Resistant Prostate Carcinoma
- +3 more
- Decitabine and Cedazuridine
- Enzalutamide
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 27, 2022
Metastatic Hormone Sensitive Prostate Cancer Trial in China (Enzalutamide, Placebo, Androgen deprivation therapy (ADT))
Active, not recruiting
- Metastatic Hormone Sensitive Prostate Cancer
- Enzalutamide
- +2 more
-
Beijing, China
- +29 more
Jan 7, 2023